225 results
8-K
EX-10.1
CPMV
Mosaic ImmunoEngineering Inc.
29 Apr 24
Regulation FD Disclosure
8:00am
(the “Oncotelic Technologies”) in exchange for equity interests in Mosaic as part of a transaction (the “Transaction”). The parties will explore the most tax … efforts within its control to convert existing liabilities of Mosaic into shares of common stock of Mosaic, provided such conversion has no tax
8-K
EX-10.1
wi1qd0 gpmi81xj
22 Feb 22
Entry into a Material Definitive Agreement
5:20pm
DEF 14C
aif6w9 vo16l
25 Jun 21
Information statement
12:05pm
PRE 14C
wg2k1se137udu1l4
15 Jun 21
Preliminary information
4:00pm
8-K
EX-10.1
jax3h p5hajv
10 May 21
Entry into a Material Definitive Agreement
4:03pm
10-KT
EX-10.7
y97i3
2 Mar 21
Annual report (with FYE transition)
1:44pm